WESCAP Management Group’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $463K | Hold |
1,735
| – | – | 0.09% | 93 |
|
|
2025
Q4 | $435K | Sell |
1,735
-230
| -12% | -$61.1K | 0.09% | 92 |
|
|
2025
Q3 | $564K | Hold |
1,965
| – | – | 0.12% | 82 |
|
|
2025
Q2 | $516K | Hold |
1,965
| – | – | 0.12% | 79 |
|
|
2025
Q1 | $457K | Hold |
1,965
| – | – | 0.11% | 79 |
|
|
2024
Q4 | $451K | Hold |
1,965
| – | – | 0.11% | 79 |
|
|
2024
Q3 | $439K | Sell |
1,965
-58
| -3% | -$12.7K | 0.11% | 76 |
|
|
2024
Q2 | $412K | Sell |
2,023
-37
| -2% | -$7.53K | 0.12% | 77 |
|
|
2024
Q1 | $450K | Sell |
2,060
-44
| -2% | -$9.69K | 0.13% | 77 |
|
|
2023
Q4 | $478K | Sell |
2,104
-106
| -5% | -$22.3K | 0.15% | 69 |
|
|
2023
Q3 | $444K | Sell |
2,210
-479
| -18% | -$101K | 0.16% | 70 |
|
|
2023
Q2 | $557K | Hold |
2,689
| – | – | 0.19% | 65 |
|
|
2023
Q1 | $530K | Sell |
2,689
-138
| -5% | -$28.4K | 0.19% | 68 |
|
|
2022
Q4 | $572K | Sell |
2,827
-157
| -5% | -$30.7K | 0.2% | 67 |
|
|
2022
Q3 | $525K | Sell |
2,984
-539
| -15% | -$110K | 0.2% | 70 |
|
|
2022
Q2 | $709K | Sell |
3,523
-5,575
| -61% | -$1.19M | 0.24% | 66 |
|
|
2022
Q1 | $2.06M | Sell |
9,098
-238
| -3% | -$56K | 0.58% | 40 |
|
|
2021
Q4 | $2.52M | Sell |
9,336
-224
| -2% | -$55.5K | 0.7% | 35 |
|
|
2021
Q3 | $2.31M | Sell |
9,560
-561
| -6% | -$141K | 0.67% | 35 |
|
|
2021
Q2 | $2.4M | Sell |
10,121
-1,127
| -10% | -$257K | 0.7% | 33 |
|
|
2021
Q1 | $2.46M | Sell |
11,248
-290
| -3% | -$58.2K | 0.68% | 34 |
|
|
2020
Q4 | $2.02M | Sell |
11,538
-711
| -6% | -$123K | 0.6% | 39 |
|
|
2020
Q3 | $1.98M | Sell |
12,249
-413
| -3% | -$65.5K | 0.66% | 36 |
|
|
2020
Q2 | $1.81M | Sell |
12,662
-230
| -2% | -$31.8K | 0.64% | 36 |
|
|
2020
Q1 | $1.4M | Buy |
12,892
+130
| +1% | +$18.7K | 0.58% | 35 |
|
|
2019
Q4 | $1.85M | Sell |
12,762
-14
| -0.1% | -$2.02K | 0.72% | 32 |
|
|
2019
Q3 | $1.84M | Sell |
12,776
-1,066
| -8% | -$156K | 0.76% | 32 |
|
|
2019
Q2 | $2.06M | Buy |
13,842
+57
| +0.4% | +$7.95K | 0.85% | 31 |
|
|
2019
Q1 | $1.81M | Sell |
13,785
-418
| -3% | -$51.5K | 0.77% | 32 |
|
|
2018
Q4 | $1.54M | Sell |
14,203
-172
| -1% | -$23K | 0.74% | 34 |
|
|
2018
Q3 | $2.14M | Sell |
14,375
-504
| -3% | -$76.7K | 1.09% | 22 |
|
|
2018
Q2 | $2.29M | Buy |
14,879
+308
| +2% | +$46.5K | 1.11% | 20 |
|
|
2018
Q1 | $2.02M | Sell |
14,571
-331
| -2% | -$48.6K | 0.81% | 31 |
|
|
2017
Q4 | $2.04M | Buy |
14,902
+175
| +1% | +$23.1K | 0.8% | 32 |
|
|
2017
Q3 | $1.91M | Sell |
14,727
-284
| -2% | -$37.9K | 0.86% | 30 |
|
|
2017
Q2 | $1.99M | Sell |
15,011
-76
| -0.5% | -$9.31K | 0.94% | 27 |
|
|
2017
Q1 | $1.86M | Sell |
15,087
-639
| -4% | -$75.7K | 0.91% | 29 |
|
|
2016
Q4 | $1.73M | Sell |
15,726
-165
| -1% | -$18.3K | 0.89% | 26 |
|
|
2016
Q3 | $1.88M | Sell |
15,891
-240
| -1% | -$28.3K | 0.98% | 23 |
|
|
2016
Q2 | $1.8M | Buy |
16,131
+1,039
| +7% | +$112K | 0.89% | 25 |
|
|
2016
Q1 | $1.52M | Sell |
15,092
-864
| -5% | -$82.8K | 0.76% | 27 |
|
|
2015
Q4 | $1.69M | Buy |
+15,956
| New | +$1.65M | 0.91% | 21 |
|
Other funds holding LH
VCM
VPM
WESCAP Management Group's LH Position: Q1 2026 in Review
WESCAP Management Group held its Labcorp (LH) position steady in Q1 2026 at 1,735 shares worth $463K. The position accounts for 0.09% of the portfolio, ranked #93.
WESCAP Management Group first reported a position in LH in Q4 2015 and has held it in 42 quarters since. The position peaked at $2.52M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- WESCAP Management Group held 1,735 shares of Labcorp worth $463K as of Q1 2026.
- WESCAP Management Group left its Labcorp share count unchanged in Q1 2026.
- Labcorp made up 0.09% of WESCAP Management Group's portfolio in Q1 2026, its #93 holding.
- WESCAP Management Group first reported a position in Labcorp in Q4 2015 and has held it in 42 quarters since.
- WESCAP Management Group's Labcorp position peaked at $2.52M in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on WESCAP Management Group's 13F filing for Q1 2026, filed 12 May 2026.